The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Positron-Emission Tomography and Assessment of Cancer Therapy
Abstract
Positron-emission tomography (PET) is a noninvasive imaging technique that exploits the unique decay physics of positron-emitting isotopes. The isotopes of oxygen, carbon, nitrogen, and fluorine have been used in the development of diagnostically useful biologic compounds that are available for PET imaging in order to provide a functional or metabolic assessment of normal tissues or disease conditions.The past few years have seen a tremendous expansion of clinical applications of PET, particularly in oncology, mostly with the use of 18F-fluorodeoxyglucose (18F-FDG) as the PET tracer. PET with 18F-FDG is now being used in the evaluation of several neoplasms, both . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lardinois, D., Weder, W., Hany, T. F., Kamel, E. M., Korom, S., Seifert, B., von Schulthess, G. K., & Steinert, H. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022136 · Cited by 1,416
(2001) · PubMed · Cited by 943
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Wahl, R. L., Zasadny, K., Helvie, M., Hutchins, G. D., Weber, B., & Cody, R. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.11.2101 · Cited by 605
Bos, R., van der Hoeven, J. J. M., van der Wall, E., van der Groep, P., van Diest, P. J., Comans, E. F. I., Joshi, U., Semenza, G. L., Hoekstra, O. S., Lammertsma, A. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.379 · Cited by 591
Jerusalem, G., Beguin, Y., Fassotte, M. F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999) · Blood · doi:10.1182/blood.v94.2.429 · Cited by 565
Gallagher, B. M., Fowler, J. S., Gutterson, N. I., MacGregor, R. R., Wan, C.-N., & Wolf, A. P. (1978) · PubMed · Cited by 557
Schelling, M., Avril, N., Nährig, J., Kuhn, W., Römer, W., Sattler, D., Werner, M., Dose, J., Jänicke, F., Graeff, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1689 · Cited by 522
Weber, W. A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., & Schwaiger, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.004 · Cited by 493
Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., De Wolf-Peeters, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.414 · Cited by 465
Utility of FDG-PET scanning in lymphoma by WHO classification
Elstrom, R., Guan, L., Baker, G., Nakhoda, K., Vergilio, J.-A., Zhuang, H., Pitsilos, S., Bagg, A., Downs, L., Mehrotra, A., et al. (2003) · Blood · doi:10.1182/blood-2002-09-2778 · Cited by 437
Antoch, G., Saoudi, N., Kuehl, H., Dahmen, G., Mueller, S. P., Beyer, T., Bockisch, A., Debatin, J. F., & Freudenberg, L. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.120 · Cited by 435
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Balzarini, J., De Wolf-Peeters, C., Mortelmans, L., & Verhoef, G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf256 · Cited by 410
Smith, I. C., Welch, A. E., Hutcheon, A. W., Miller, I. D., Payne, S., Chilcott, F., Waikar, S., Whitaker, T., Ah-See, A. K., Eremin, O., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1676 · Cited by 406
Juweid, M. E., Wiseman, G. A., Vose, J. M., Ritchie, J. M., Menda, Y., Wooldridge, J. E., Mottaghy, F. M., Rohren, E. M., Blumstein, N. M., Stolpen, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.891 · Cited by 387
Self-citationSchaefer, N. G., Hany, T. F., Taverna, C., Seifert, B., Stumpe, K. D. M., von Schulthess, G. K., & Goerres, G. W. (2004) · Radiology · doi:10.1148/radiol.2323030985 · Cited by 364
Selzner, M., Hany, T. F., Wildbrett, P., McCormack, L., Kadry, Z., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000146145.69835.c5 · Cited by 348
Römer, W., Hanauske, A.-R., Ziegler, S. I., Thödtmann, R., Weber, W., Fuchs, C., Enne, W., Herz, M., Nerl, C., Garbrecht, M., et al. (1998) · PubMed · doi:10.1182/blood.v91.12.4464 · Cited by 335
Wang, W. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.7.2291 · Cited by 330
Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.-J., Busch, R., Stein, H., Lordick, F., Link, T., Schwaiger, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.574 · Cited by 318
Findlay, M., Young, H., Cunningham, D., Iveson, A., Cronin, B., Hickish, T., Pratt, B., Husband, J., Flower, M., & Ott, R. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.700 · Cited by 310
Whole-Body PET Imaging With [18F]Fluorodeoxyglucose in Management of Recurrent Colorectal Cancer
Valk, P. E. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.5.503 · Cited by 291
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Büll, U., & Jakse, G. (1996) · PubMed · Cited by 289
Moon, D. H., Maddahi, J., Silverman, D. H. S., Glaspy, J. A., Phelps, M. E., & Hoh, C. K. (1998) · PubMed · Cited by 274
PET and [18F]-FDG in oncology: A clinical update
Conti, P. S., Lilien, D. L., Hawley, K., Keppler, J., Grafton, S. T., & Bading, J. R. (1996) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(96)00074-1 · Cited by 259
Flanagan, F. L., Dehdashti, F., Ogunbiyi, O. A., Kodner, I. J., & Siegel, B. A. (1998) · Annals of Surgery · doi:10.1097/00000658-199803000-00001 · Cited by 253
Brun, E., Kjellén, E., Tennvall, J., Ohlsson, T., Sandell, A., Perfekt, R., Perfekt, R., Wennerberg, J., & Strand, S. E. (2002) · Head & Neck · doi:10.1002/hed.10037 · Cited by 251
Schlüter, B., Bohuslavizki, K. H., Beyer, W., Plotkin, M., Buchert, R., & Clausen, M. (2001) · PubMed · Cited by 240
Effert, P. J., Bares, R., Handt, S., Wolff, J. M., Bull, U., & Jakse, G. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)66366-3 · Cited by 240
Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography
Lowe, V. J., Boyd, J. H., Dunphy, F. R., Kim, H., Dunleavy, T., Collins, B. T., Martin, D., Stack, B. C., Hollenbeak, C., & Fletcher, J. W. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.651 · Cited by 239
Residual mass in lymphoma may not be residual disease.
Canellos, G. P. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.6.931 · Cited by 220
Keidar, Z., Haim, N., Guralnik, L., Wollner, M., Bar‐Shalom, R., Ben‐Nun, A., & Israel, O. (2004) · PubMed · Cited by 219
Detecting recurrent or residual lung cancer with FDG-PET
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90602-9 · Cited by 203
Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
Patz, E. F., Lowe, V. J., Hoffman, J. M., Paine, S., Harris, L. K., & Goodman, P. C. (1994) · Radiology · doi:10.1148/radiology.191.2.8153309 · Cited by 202
Flamen, P., Lerut, A., Van Cutsem, E., Cambier, J. P., Maes, A., De Wever, W., Peeters, M., De Leyn, P., Van Raemdonck, D., & Mortelmans, L. (2000) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2000.110464 · Cited by 174
Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer
Bury, T., Jl, C., Duysinx, B., Daenen, F., Ghaye, B., Barthélémy, N., Rigo, P., & Bartsch, P. (1999) · European Respiratory Journal · doi:10.1183/09031936.99.14613769 · Cited by 154
A radiosynthesis of fluorine-18 fluoromisonidazole.
Grierson, J. R., Link, J. M., Mathis, C. A., Rasey, J. S., & Krohn, K. A. (1989) · PubMed · Cited by 153
Hathaway, P. B., Mankoff, D. A., Maravilla, K. R., Austin-Seymour, M., Ellis, G. K., Gralow, J. R., Cortese, A. A., Hayes, C. E., & Moe, R. E. (1999) · Radiology · doi:10.1148/radiology.210.3.r99mr43807 · Cited by 127
A review of the literature for whole-body FDG PET in the management of patients with melanoma.
Schwimmer, J., Essner, R., Patel, A., Jahan, S., Shepherd, J. E., Park, K., Phelps, M. E., Czernin, J., & Gambhir, S. S. (2000) · PubMed · Cited by 125
Fuster, D., Chiang, S. B., Johnson, G. R., Schuchter, L. M., Zhuang, H., & Alavi, A. A. (2004) · PubMed · Cited by 125
Allen-Auerbach, M., Quon, A. S. W., Weber, W., Obrzut, S. L., Crawford, T. L., Silverman, D. H. S., Ratib, O. M., Phelps, M. E., & Czernin, J. G. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.08.004 · Cited by 122
Role of Positron Emission Tomography in Lymphoma
Juweid, M. E., & Cheson, B. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.904 · Cited by 115
Self-citationLapela, M., Eigtved, A., Jyrkkiö, S. M., Grenman, R. A., Kurki, T. J. I., Lindholm, P., Nuutinen, J., Sutinen, E., Solin, O. H., Bjørnskov, I., et al. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00037-x · Cited by 113
Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma
Kato, H., Miyazaki, T., Nakajima, M., Fukuchi, M., Manda, R., & Kuwano, H. (2004) · British journal of surgery · doi:10.1002/bjs.4595 · Cited by 91
Bender, H., BANGARD, N., METTEN, N., Bangard, M., Mezger, J. M., Schomburg, A., & BIERSACK, H.-J. (1999) · Hybridoma · doi:10.1089/hyb.1999.18.87 · Cited by 54
vonSchulthess, G. (2004) · Molecular Imaging and Biology · doi:10.1016/j.mibio.2004.05.001 · Cited by 43
Cited by
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
Self-citationFrom RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
“Since that report, there have been many others in a wide range of tumors (21,22).”
BackgroundJuweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335
Self-citationWeissleder, R. (2006) · Science · doi:10.1126/science.1125949 · Cited by 1,112
Strategies for Safer Liver Surgery and Partial Liver Transplantation
Clavien, P.-A., Petrowsky, H., DeOliveira, M. L., & Graf, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra065156 · Cited by 1,022
Metadata
- Authors
- Juweid, M. E., & Cheson, B. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-02-02
- Volume
- 354
- Issue
- 5
- Pages
- 496-507
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2084693381
- Cited by
- 750
- References
- 46
- FWCI
- 59.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.